
Finflexity
@finflexity
Followers
790
Following
2K
Media
507
Statuses
6K
Financial analyst covering technology, mobility & growth. Follow for earnings summaries, equity research, visualizations & great insights: all in one feed.
Joined August 2023
$GOOGL / $TSLA / $BIDU: BofA released a detailed primer on the future of robotaxis following Tesla's Austin launch. If you're investing in any AV company, its a must read. I'll try to recap everything that stood out to me. A Thread ๐งต.
1
1
3
RT @finflexity: @elonmusk @fightoracle @DillonLoomis22 Many here lack background on this topic. Here's my research from Sam's board ouster:โฆ.
0
1
0
The White House has tapped .@RealEJAntoni to lead the BLS. He's obviously smart and has been a vocal critic of data problems. Hopefully he can pass the senate and actually get the BLS to digitize their processes.
0
0
0
This is a list of all nuclear plays I identified last year, I will try to maybe do some deep dives into them later. If you're looking for plays in these industries, @pennycheck will be your best bet, not me.
Nuclear Energy: I have compiled a list of all plays in the nuclear sector (most have soared recently), and linked the excel file in the comments. This is just a list of plays, you can conduct your own research on them. $DOW $CCJ $GOOGL $AMZN $MSFT $META $OKLO
0
0
0
$TSLA: The Dojo project has been disbanded with key employees leaving and others being re-assigned. Going forward, Tesla will increase reliance on $NVDA & $AMD for compute. Reported by Bloomberg - @EdLudlow.
0
0
0
$LLY: Eli Lilly shares fell by 12% as the company released results from its obesity pill trials. Orforglipron users shed on average 11% of their weight, compared to $NOVO's Wegovy at 15%. Does it really matter, probably not. The pill is easier to manufacture, significantly.
$LLY: Eli Lilly reports earnings today, with Wall Street expecting $5.57 EPS and $14.7B in revenue. In Q1, Mounjaro generated nearly $4B in revenue, up over 100% year-over-year, while Zepbound contributed $2.3B, nearly quadrupling from $517M last year. Together, these drugs
0
0
0